Majutec Co., Ltd. (CEO Kwak No-woong) participated in the 3th International Medical Equipment and Hospital Equipment Exhibition ‘KIMES 23’ held at COEX, Seoul from March 26rd (Thursday) to 38th (Sunday).
Founded in 2015, Majutec aims to expand its business into venous blood vessel analysis equipment through continuous technological innovation in the vein viewer system field.
At KIMES 2023, the recently upgraded ‘VeinVu 200’ system was introduced. In particular, the official explains that through the blood vessel image optimization algorithm, clear and accurate blood vessel viewer performance and color-based blood vessel images can be viewed with clearer distinctions in the vein images.
A Majutec official said, “Using our product, even patients who cannot see blood vessels can see accurate and clear images of venous blood vessels and perform intravenous injections more easily and conveniently without failure. “This is an essential product for intravenous injections that can be helpful to all medical personnel, patients, and hospitals by reducing the pain caused by multiple stabbings, reducing the burden on medical personnel due to failure, and reducing economic losses such as disposable consumables and time costs.” explained.
To emphasize this, Majutec demonstrated the ability to directly check blood vessels with the VeinVu 200 vein viewer system at the exhibition site.
An official said, “In the case of vein viewer products, they are sold and used in a variety of places, including hospitals that require intravenous injections (pediatrics, internal medicine, emergency room, blood collection room, ward), diagnostic testing, plastic surgery, emergency rescue, and health education fields. . In Korea, the VeinVu 200 Veinfinder product is being used in pediatric hospitals, general hospitals, university hospitals, and educational institutions, and we are receiving many inquiries,” he said. “Overseas, we are exporting to 20 countries with excellent performance and quality. it started. Some countries have completed 3-5 year exclusive rights contracts, and discussions on exclusive rights are in progress with several countries. “We are expecting to expand exports based on stable sales through exclusive rights,” he said, announcing the achievements so far.
He continued, “In the future, we are planning a VeinVu 300 product that can view deep venous blood vessels and a product that can be used in various fields by using the speed of blood flow. “Based on these two products, we plan to challenge the product line using consumables,” he said. “We aim to provide optimal solutions by commercializing innovative ideas demanded by the market with the best technology. “In addition, we will become a global small but strong company that listens more closely to the voices of customers so that we can develop products that can be helpful to medical professionals, patients, and companies alike.”
On the other hand, KIMES is an exhibition specializing in medical devices and hospital facilities that has grown steadily with the development of the Korean medical industry since its first meeting in 1980. It has transformed into a technology-intensive high-tech industry such as rehabilitation medicine.
In KIMES 2023, new technologies and products suitable for the era of convergence, such as smart healthcare in the era of the 4th industrial revolution, robot medical care and eco-friendly medical waste facilities, advanced hospital facilities, medical information systems combined with IT technology, and the automobile industry for rapid patient transportation, will be presented. showed off In addition, various information was provided, including seminars on medical technology, new technologies, and overseas marketing, as well as domestic medical industry policy seminars to show the latest information and the direction of the medical industry.
→ Go to KIMES 2023 news special page
